Skip to main content

Precursion Biosciences

Announcement
Firalis Molecular Precision is now Precursion
A renewed identity in service of precision research.

Firalis Molecular Precision attends Olink User Group Meeting to enhance service offerings

At Firalis Molecular Precision, we’re always looking for ways to enhance our services and deepen our expertise to be able to provide you with a tailored, expert solution to help you face your research challenge.

That’s why our team attended this year’s Olink Proteomics User Group Meeting (UGM) in Barcelona, Spain.

The UGM brought together a global community of experts to share insights on how proteomics is revolutionizing multiomics workflows, driving biomarker identification, and deepening our understanding of complex disease mechanisms.

This collaborative event provided an opportunity for our proteomics specialists to deepen their expertise in Olink technology and to explore innovations and advancements in the field.

As a CRO, we are constantly striving to refine and perfect our services. Attending events like the Olink UGM allows us to gain further insights into how emerging technologies can support our mission of delivering precise, high-throughput proteomics solutions to support drug development, diagnostics, and personalized medicine.

Latest posts

Firalis Molecular Becomes Precursion

Firalis Molecular Becomes Precursion

Firalis Molecular Precision is now Precursion 15.06.26 Huningue, France, 15/06/2026 – Firalis Molecular Precision, a company specializing in biomarkers and multi-omics analysis for precision medicine...
Meet our Team at The European Society of Human Genetics (ESHG) 2026

Meet our Team at The European Society of Human Genetics (ESHG) 2026

Firalis Molecular Precision is excited to be a part of Biomarkers US 2024 in San Diego on October 28-29. As a provider of bioanalytical solutions, we’ll be discussing how our biobanking, bioanalytical...
Webinar : Detecting Alzheimer’s disease subtypes with serum proteomics

Webinar : Detecting Alzheimer’s disease subtypes with serum proteomics

We are pleased to announce an upcoming webinar in collaboration with Olink, Part of Thermo Fisher, titled “Detecting Alzheimer’s Disease Subtypes with Serum Proteomics”, showcasing how advanced...

Share this article on your socials

Stay Connected with Precursion

Great! We’ve received your information.